Blog
Mitsubishi UFJ Financial Group Q4 Earnings Call Highlights
Key Points
- Interested in Mitsubishi UFJ Financial Group, Inc.? Here are five stocks we like better.
- MUFG posted record fiscal 2025 profit and lifted its fiscal 2026 profit target to JPY 2.7
SCHMID Group Q4 Earnings Call Highlights
Key Points
- Interested in SCHMID Group N.V.? Here are five stocks we like better.
- SCHMID Group expects stronger demand in 2026 as AI infrastructure, optical modules, and advanced packaging
Consumer-Driven Stocks Boost Buybacks, Including Visa's $20B Plan
Key Points
- Interested in Visa Inc.? Here are five stocks we like better.
- Consumer-driven stocks have boosted their buyback capacity significantly, from 5% to 12% of their market capitalizations.
TOYO Q1 Earnings Call Highlights
Key Points
- Interested in TOYO Co., Ltd.? Here are five stocks we like better.
- TOYO posted a strong Q1 fiscal 2026 turnaround, with revenue surging 177% year over year to about $142.8 million
ReNew Energy Global Q4 Earnings Call Highlights
Key Points
- Interested in ReNew Energy Global PLC? Here are five stocks we like better.
- ReNew Energy Global said fiscal 2026 was its strongest year yet, with operating portfolio capacity rising
Compugen Q1 Earnings Call Highlights
Key Points
- Interested in Compugen Ltd.? Here are five stocks we like better.
- COM701 ovarian trial is on schedule: Compugen said all sites are open and enrolling in its MAIA-ovarian study, and
Baidu Q1 Earnings Call Highlights
Key Points
- Interested in Baidu, Inc.? Here are five stocks we like better.
- AI became Baidu’s main growth engine in Q1 2026, with core AI-powered revenue up 49% year over year to CNY 13.6
Willing and Abel: Berkshire's New CEO Makes Huge Portfolio Changes in Q1
Key Points
- Interested in Berkshire Hathaway Inc.? Here are five stocks we like better.
- Berkshire Hathaway's new CEO isn't making a quiet entrance when it comes to portfolio moves.
- Berkshire's Q1
Niu Technologies Q1 Earnings Call Highlights
Key Points
- Interested in Niu Technologies? Here are five stocks we like better.
- Niu’s Q1 2026 revenue and volume surged, with total sales volume rising about 29% year over year to roughly
NRx Pharmaceuticals Q1 Earnings Call Highlights
Key Points
- Interested in NRx Pharmaceuticals, Inc.? Here are five stocks we like better.
- KETAFREE moved closer to a potential summer 2026 approval after the FDA issued mostly minor review
iQIYI Q1 Earnings Call Highlights
Key Points
- Interested in iQIYI, Inc. Sponsored ADR? Here are five stocks we like better.
- Membership revenue improved sequentially to CNY 4.2 billion in Q1, helped by hit dramas such as “The
Gossamer Bio Q1 Earnings Call Highlights
Key Points
- Interested in Gossamer Bio, Inc.? Here are five stocks we like better.
- Gossamer Bio is still targeting a September 2026 NDA submission for seralutinib in pulmonary arterial
J.B. Hunt Says Freight Rates Are Rising as Capacity Tightens, Not Demand
Key Points
- Interested in J.B. Hunt Transport Services, Inc.? Here are five stocks we like better.
- J.B. Hunt says freight rates are rising, but executives stressed the improvement is being
Kainos Group H2 Earnings Call Highlights
Key Points
- Interested in Kainos Group plc? Here are five stocks we like better.
- Kainos Group said it has returned to growth, with sales bookings up 32% to GBP 505 million, revenue rising to
iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains
Key Points
- Interested in iRhythm Technologies? Here are five stocks we like better.
- iRhythm said a favorable Medicare local coverage determination expanded access for its services, while the
Ionis Pharmaceuticals Touts $3B TRYNGOLZA Opportunity, Pipeline Readouts at Conference
Key Points
- Interested in Ionis Pharmaceuticals, Inc.? Here are five stocks we like better.
- Ionis Pharmaceuticals said TRYNGOLZA could become a more than $3 billion U.S. product in severe
SMA Solar Technology Q1 Earnings Call Highlights
Key Points
- Interested in SMA Solar Technology AG? Here are five stocks we like better.
- SMA Solar posted modest Q1 2026 growth, with sales up 4% to EUR 341 million and operating EBITDA rising
Insmed CEO Defends BRINSUPRI Launch as Sales Surge, TPIP Pipeline Gains Focus
Key Points
- Interested in Insmed, Inc.? Here are five stocks we like better.
- Insmed defended the BRINSUPRI launch after investors worried about discontinuation rates, saying the drug’s $208
Incyte CEO Says Post-Jakafi Growth Path Is Clearer as Pipeline Catalysts Build
Key Points
- Interested in Incyte Corporation? Here are five stocks we like better.
- Incyte’s CEO says the company’s post-Jakafi growth path is becoming clearer as its commercial business
IDEAYA Biosciences Says Melanoma Drug on Track for NDA After Strong Trial Data
Key Points
- Interested in IDEAYA Biosciences, Inc.? Here are five stocks we like better.
- IDEAYA Biosciences said its lead melanoma drug, darovasertib, is on track for an NDA submission after
InterDigital Maps Path to $1B Recurring Revenue on Patents, Streaming Push
Key Points
- Interested in InterDigital, Inc.? Here are five stocks we like better.
- InterDigital said it is on track toward a long-term goal of more than $1 billion in annualized recurring
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief
Henry Schein Highlights Dental Momentum, $125M Savings Goal Despite Medical Softness
Henry Schein (NASDAQ:HSIC) executives said the company is seeing continued momentum in its dental business and remains committed to previously outlined operating improvement targets, while
Horizon Quantum Computing Pte. Lays Out Quantum Software Push at Needham Conference
Horizon Quantum Computing Pte. (NASDAQ:HQ) used its appearance at Needham & Company’s 21st annual Technology, Media, & Consumer
GRAIL Says Galleri Demand Is Rising as NHS Talks, FDA Review Move Ahead
GRAIL (NASDAQ:GRAL) said demand for its Galleri multi-cancer early detection test has continued to grow despite recent headlines related